Joel D. Posligua-Garcia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joel D. Posligua-Garcia has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Manuel Bernal
University of Malaga
4 shared publications - Miguel Ángel Medina
Universidad de Málaga
3 shared publications - Ana Dácil Marrero
Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, Andalucía Tech, 29071 Málaga, Spain
1 shared publication - Ana Rodriguez Quesada
Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Andalucía Tech, Universidad de Málaga, E-29071 Málaga, Spain
1 shared publication - Ana Sanchez-Molina
Universidad Pablo de Olavide / Centro Andaluz de Biologia del Desarrollo
1 shared publication - Antonio J. Pérez Pulido
Andalusian Centre for Developmental Biology (CABD, UPO-CSIC-JA), Faculty of Experimental Sciences (Genetics Area), University Pablo de Olavide, 41013 Seville, Spain
1 shared publication
Latest Publications
- Open Access
- 4 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1533
Punicalin Modulates Angiogenesis and Tumor Microenvironment-Related Processes in Triple-Negative Breast Cancer and Endothelial Cells
The tumor microenvironment plays a critical role in cancer progression, with oxidative stress, autophagy, angiogenesis, and cell migration acting as tightly interconnected processes. Natural bioactive compounds have emerged as promising modulators of these pathways; however, their cell type-specific effects within the TME remain poorly understood. In this study, we investigate the effects of punicalin on triple-negative breast cancer and endothelial cells, with a focus on redox homeostasis and autophagy as upstream regulatory mechanisms. Punicalin reduced oxidative stress in MDA-MB-231 cells under basal conditions and strongly attenuated hydrogen peroxide-induced stress, whereas HMEC-1 cells exhibited concentration- and condition-dependent reactive oxygen species (ROS) modulation. Autophagy assays revealed no significant modulation in tumor cells, while a consistent and pronounced decrease in autophagic activity was observed in endothelial cells under both basal and nutrient-deprivation conditions. Functionally, punicalin decreased tumor cell migration and impaired HMEC-1 migration, while HUVEC migration remained largely unaffected. Tube formation assays demonstrated significant inhibition of angiogenic capacity. Taken together, these findings demonstrate that punicalin selectively modulates oxidative stress and autophagy, leading to functional alterations in migration and angiogenesis. By highlighting its selective impact on microvascular endothelial cells while sparing normal endothelium, this study provides a strong rationale for further preclinical evaluation of punicalin.
- 4 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1533
Open AccessPunicalin Modulates Angiogenesis and Tumor Microenvironment-Related Processes in Triple-Negative Breast Cancer and Endothelial Cells
The tumor microenvironment plays a critical role in cancer progression, with oxidative stress, autophagy, angiogenesis, and cell migration acting as tightly interconnected processes. Natural bioactive compounds have emerged as promising modulators of these pathways; however, their cell type-specific effects within the TME remain poorly understood. In this study, we investigate the effects of punicalin on triple-negative breast cancer and endothelial cells, with a focus on redox homeostasis and autophagy as upstream regulatory mechanisms. Punicalin reduced oxidative stress in MDA-MB-231 cells under basal conditions and strongly attenuated hydrogen peroxide-induced stress, whereas HMEC-1 cells exhibited concentration- and condition-dependent reactive oxygen species (ROS) modulation. Autophagy assays revealed no significant modulation in tumor cells, while a consistent and pronounced decrease in autophagic activity was observed in endothelial cells under both basal and nutrient-deprivation conditions. Functionally, punicalin decreased tumor cell migration and impaired HMEC-1 migration, while HUVEC migration remained largely unaffected. Tube formation assays demonstrated significant inhibition of angiogenic capacity. Taken together, these findings demonstrate that punicalin selectively modulates oxidative stress and autophagy, leading to functional alterations in migration and angiogenesis. By highlighting its selective impact on microvascular endothelial cells while sparing normal endothelium, this study provides a strong rationale for further preclinical evaluation of punicalin.
- Open Access
Dynamic Tracking and Single-Cell Analysis of Starvation-Induced Autophagic Responses in Breast Cancer Cells
Autophagy is a fundamental cellular process that enables adaptation to metabolic stress and has emerged as a critical modulator of cancer progression. However, how autophagy contributes to phenotypic heterogeneity at the single-cell level remains poorly understood. Here, we leverage High-Content Screening (HCS) coupled with time-lapse imaging and advanced single-cell segmentation to systematically dissect autophagic dynamics in two breast cancer models: MDA-MB-231 (triple-negative) and MCF-7 (estrogen receptor-positive) under nutrient deprivation. By tracking individual cells over time, we quantified key morphological and fluorescence-based autophagic markers, revealing distinct subpopulations with differential autophagic responses. Notably, we observed a significant temporal shift in the proportion of cells transitioning from near-average autophagic activity to outlier states, a phenomenon more pronounced in MDA-MB-231 cells (3.7% to 8.6%) than in MCF-7 cells (3.1% to 4.7%). This dynamic heterogeneity would remain undetectable in conventional endpoint assays, underscoring the power of real-time single-cell analysis. Our approach further identified rare cell subsets with unique autophagic profiles, shedding light on cellular plasticity and adaptive mechanisms that may drive tumor progression and therapeutic resistance. By integrating HCS with single-cell tracking, this study provides a novel framework for resolving the complexity of autophagy in cancer. Our findings highlight the necessity of temporally resolved analyses to capture dynamic cellular behaviors that static measurements overlook. These insights advance our understanding of tumor heterogeneity and stress adaptation, offering a refined perspective on autophagy as a potential therapeutic target in breast cancer. Graphical
Open AccessDynamic Tracking and Single-Cell Analysis of Starvation-Induced Autophagic Responses in Breast Cancer Cells
Autophagy is a fundamental cellular process that enables adaptation to metabolic stress and has emerged as a critical modulator of cancer progression. However, how autophagy contributes to phenotypic heterogeneity at the single-cell level remains poorly understood. Here, we leverage High-Content Screening (HCS) coupled with time-lapse imaging and advanced single-cell segmentation to systematically dissect autophagic dynamics in two breast cancer models: MDA-MB-231 (triple-negative) and MCF-7 (estrogen receptor-positive) under nutrient deprivation. By tracking individual cells over time, we quantified key morphological and fluorescence-based autophagic markers, revealing distinct subpopulations with differential autophagic responses. Notably, we observed a significant temporal shift in the proportion of cells transitioning from near-average autophagic activity to outlier states, a phenomenon more pronounced in MDA-MB-231 cells (3.7% to 8.6%) than in MCF-7 cells (3.1% to 4.7%). This dynamic heterogeneity would remain undetectable in conventional endpoint assays, underscoring the power of real-time single-cell analysis. Our approach further identified rare cell subsets with unique autophagic profiles, shedding light on cellular plasticity and adaptive mechanisms that may drive tumor progression and therapeutic resistance. By integrating HCS with single-cell tracking, this study provides a novel framework for resolving the complexity of autophagy in cancer. Our findings highlight the necessity of temporally resolved analyses to capture dynamic cellular behaviors that static measurements overlook. These insights advance our understanding of tumor heterogeneity and stress adaptation, offering a refined perspective on autophagy as a potential therapeutic target in breast cancer. Graphical
- Open Access
Hydroxyurea induces ER stress and cytoplasmic protein aggregation
The endoplasmic reticulum (ER) lumen provides the proper redox environment for disulfide bond formation, which is required for the appropriate folding of proteins that enter the secretory pathway and constitute membranes. Defective protein folding in the ER activates proteostatic mechanisms that are now beginning to be elucidated. Here, we show that hydroxyurea (HU) causes ER stress and triggers a transient perinuclear ER expansion, which leads to the clustering of nuclear pore complexes. This striking phenotype is mimicked by diamide (DIA), a specific thiol stress inductor, and prevented or rapidly reverted by dithiothreitol, a dithiol-reducing agent, suggesting that ER expansion is caused by disulfide stress. ER expansion induced by HU or DIA depends on glutathione (GSH), is Ire1-independent, and is associated with a unique transcriptome program that differs from the canonical unfolding protein response (UPR). The ER luminal expansion accumulates Hsp70 Bip1 chaperone, and it evolves parallel with the appearance of cytoplasmic protein aggregates containing heat stress proteins (HSPs), indicating that both HU and DIA are impinging on protein folding. Thus, our data reveal that HU induces disulfide stress that impinges on protein folding in the cytoplasm and ER.
Open AccessHydroxyurea induces ER stress and cytoplasmic protein aggregation
The endoplasmic reticulum (ER) lumen provides the proper redox environment for disulfide bond formation, which is required for the appropriate folding of proteins that enter the secretory pathway and constitute membranes. Defective protein folding in the ER activates proteostatic mechanisms that are now beginning to be elucidated. Here, we show that hydroxyurea (HU) causes ER stress and triggers a transient perinuclear ER expansion, which leads to the clustering of nuclear pore complexes. This striking phenotype is mimicked by diamide (DIA), a specific thiol stress inductor, and prevented or rapidly reverted by dithiothreitol, a dithiol-reducing agent, suggesting that ER expansion is caused by disulfide stress. ER expansion induced by HU or DIA depends on glutathione (GSH), is Ire1-independent, and is associated with a unique transcriptome program that differs from the canonical unfolding protein response (UPR). The ER luminal expansion accumulates Hsp70 Bip1 chaperone, and it evolves parallel with the appearance of cytoplasmic protein aggregates containing heat stress proteins (HSPs), indicating that both HU and DIA are impinging on protein folding. Thus, our data reveal that HU induces disulfide stress that impinges on protein folding in the cytoplasm and ER.
- Open Access
- 28 July 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (8) , 1513
Inhibition of Endothelial Inflammatory Response by HT-C6, a Hydroxytyrosol Alkyl Ether Derivative
Hydroxytyrosol (HT) is a bioactive phenolic compound naturally present in olives and extra virgin olive oil (EVOO) which is described as an antioxidant, antitumoral and antiangiogenic molecule. Previous studies of semi-synthetic HT-derivatives presented the hydroxytyrosyl alkyl ether HT-C6 as one of the most potent derivatives studied in the context of antioxidant, anti-platelet and antiangiogenic assays, but its direct effect on inflammation was not reported. In this work, we use RT-qPCR measure of gene expression, protein analysis by Western-blot and immunofluorescence techniques, adhesion and migration functional assays and single-cell monitoring of reactive oxygen species (ROS) in order to explore in vitro the ability of HT-C6 to interfere in the inflammatory response of endothelial cells (ECs). Our results showed that HT-C6 strongly reduces the TNF-α-induced expression of vascular cell adhesion molecule 1 (VCAM1), intercellular cell adhesion molecule 1 (ICAM1), E-selectin (SELE), C-C motif chemokine ligand 2 and 5 (CCL2 and CCL5) in HUVECs, impairing the chemotactic and adhesion potential of these cells towards THP-1 monocytes in vitro. In this work, we define a mechanism of action underlying the anti-inflammatory effect of HT-C6, which involves the abrogation of nuclear factor kappa B (NF-κB) pathway activation in ECs. These results, together with the ability of HT-C6 to reduce ROS formation in ECs, point to this compound as a promising HT-derivative to be tested in the treatment of atherosclerosis.
- 28 July 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (8) , 1513
Open AccessInhibition of Endothelial Inflammatory Response by HT-C6, a Hydroxytyrosol Alkyl Ether Derivative
Hydroxytyrosol (HT) is a bioactive phenolic compound naturally present in olives and extra virgin olive oil (EVOO) which is described as an antioxidant, antitumoral and antiangiogenic molecule. Previous studies of semi-synthetic HT-derivatives presented the hydroxytyrosyl alkyl ether HT-C6 as one of the most potent derivatives studied in the context of antioxidant, anti-platelet and antiangiogenic assays, but its direct effect on inflammation was not reported. In this work, we use RT-qPCR measure of gene expression, protein analysis by Western-blot and immunofluorescence techniques, adhesion and migration functional assays and single-cell monitoring of reactive oxygen species (ROS) in order to explore in vitro the ability of HT-C6 to interfere in the inflammatory response of endothelial cells (ECs). Our results showed that HT-C6 strongly reduces the TNF-α-induced expression of vascular cell adhesion molecule 1 (VCAM1), intercellular cell adhesion molecule 1 (ICAM1), E-selectin (SELE), C-C motif chemokine ligand 2 and 5 (CCL2 and CCL5) in HUVECs, impairing the chemotactic and adhesion potential of these cells towards THP-1 monocytes in vitro. In this work, we define a mechanism of action underlying the anti-inflammatory effect of HT-C6, which involves the abrogation of nuclear factor kappa B (NF-κB) pathway activation in ECs. These results, together with the ability of HT-C6 to reduce ROS formation in ECs, point to this compound as a promising HT-derivative to be tested in the treatment of atherosclerosis.